A detailed history of Mcf Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mcf Advisors LLC holds 174 shares of VRTX stock, worth $71,023. This represents 0.01% of its overall portfolio holdings.

Number of Shares
174
Previous 176 1.14%
Holding current value
$71,023
Previous $82,000 2.44%
% of portfolio
0.01%
Previous 0.01%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$460.0 - $505.78 $920 - $1,011
-2 Reduced 1.14%
174 $80,000
Q2 2024

Aug 05, 2024

BUY
$392.81 - $485.53 $7,070 - $8,739
18 Added 11.39%
176 $82,000
Q1 2024

Apr 16, 2024

SELL
$407.69 - $446.08 $2,038 - $2,230
-5 Reduced 3.07%
158 $66,000
Q4 2023

Feb 01, 2024

BUY
$343.0 - $410.68 $2,401 - $2,874
7 Added 4.49%
163 $66,000
Q3 2023

Oct 19, 2023

BUY
$338.18 - $362.46 $37,199 - $39,870
110 Added 239.13%
156 $54,000
Q1 2023

Apr 18, 2023

BUY
$283.23 - $323.1 $11,045 - $12,600
39 Added 557.14%
46 $14,000
Q1 2022

May 05, 2022

BUY
$221.42 - $260.97 $1,549 - $1,826
7 New
7 $1,000
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $2,124 - $2,681
-12 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $2,176 - $2,435
12 New
12 $2,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.